Q3 2025 13F Holders as of 9/30/2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
88.6M
-
Number of holders
-
2
-
Total 13F shares, excl. options
-
93.6K
-
Shares change
-
-1.01M
-
Total reported value, excl. options
-
$2.24M
-
Value change
-
-$24.1M
-
Number of sells
-
-2
-
Price
-
$23.90
Significant Holders of Travere Therapeutics, Inc. - Common Stock (TVTX) as of Q3 2025
2 filings reported holding TVTX - Travere Therapeutics, Inc. - Common Stock as of Q3 2025.
Travere Therapeutics, Inc. - Common Stock (TVTX) has 2 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 93.6K shares
of 88.6M outstanding shares and own 0.11% of the company stock.
Largest 2 shareholders include Assenagon Asset Management S.A. (93.4K shares) and GAMMA Investing LLC (262 shares).
This table shows the top 2 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.